FE
62
2
DOW
62
2
MO
45
-2
PSX
70
-4
O
48
-14
ECL
59
-3
UNP
50
2
AAP
26
-7
XOM
57
-2
MS
61
2
PCAR
56
11
D
58
5
VRSN
66
4
RSG
54
4
JCI
51
-3
EFX
30
3
KMB
42
-2
WM
80
6
ICE
63
6
COST
53
2
FE
62
2
DOW
62
2
MO
45
-2
PSX
70
-4
O
48
-14
ECL
59
-3
UNP
50
2
AAP
26
-7
XOM
57
-2
MS
61
2
PCAR
56
11
D
58
5
VRSN
66
4
RSG
54
4
JCI
51
-3
EFX
30
3
KMB
42
-2
WM
80
6
ICE
63
6
COST
53
2
Financhill
Back

JPMorgan US Value Factor ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
43

JVAL
JPMorgan US Value Factor ETF

Last Price:
$49.25
Seasonality Move:
3.87%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Sell
43
JPMorgan US Value Factor ETF (JVAL) is a Sell

Is JPMorgan US Value Factor ETF a Buy, Sell or Hold?

  • The current JPMorgan US Value Factor ETF [JVAL] share price is $49.37. The Score for JVAL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • JVAL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

JVAL Stock Price Chart

What is JPMorgan US Value Factor ETF's stock price today?

  • The JPMorgan US Value Factor ETF share price today is $49.37
    The current trend is relatively stagnant and JVAL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

JVAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 49 Sell
Chaikin Money Flow: 25199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.53 - 50.47) Sell
Bollinger Bands (100): (48.42 - 51.22) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

JVAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.71 Buy
20-day SMA: 49.12 Buy
50-day SMA: 50.47 Sell
200-day SMA: 48.05 Buy
8-day EMA: 48.88 Buy
20-day EMA: 49.25 Buy
50-day EMA: 49.82 Sell
200-day EMA: 48.12 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

JPMorgan US Value Factor ETF Earnings Growth & JVAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

JPMorgan US Value Factor ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):